www.companiesandmarkets.com: Omrix Biopharmaceuticals Inc-Therapeutic Competitors

Therapeutic Competitors include a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indication and stage of development, and competitors by therapeutic indication. The report also includes recent company news updates.

Competitor Reports provide detailed analysis of a company's products by therapeutic indication, a summary of its overall pipeline as well as insight into the predicted likelihood of clinical success for each pipeline product. Every Competitor Report compares the company against its primary competitors by individual therapeutic indication.

Scope of the reports

Life Science Analytics' Competitor Reports deliver detailed analysis of a company's preclinical, clinical and marketed pipeline of products.

A complete listing of each company's entire pipeline is provided along with graphical and tabular presentation of the pipeline by therapeutic or disease category.

Every Competitor Report lists a company's individual marketed and pipeline products by disease area, as well as detail on public and private company competitors for each.

An overview of each company's discontinued product line provides insight into product attrition rates.

Life Science Analytics' Competitor Reports provide extensive information including: Company business descriptions Product pipelines by stage of development including discontinued products Therapeutic areas of research Indications treated An extensive list of competitors by disease indication.

Key benefits

Competitor Reports provide the user with independent insight into a company's management structure, financial position and products - vital intelligence for investors, competitors and partners.

Understand the uniqueness of a company's pipeline by obtaining detail on competitive products in development by other public and private companies - independent information that will enable the user to make informed strategic decisions.

Graphical representation of data coupled with detailed listings of all products in development and in production allows the user to quickly assess the depth of a company's pipeline and the strength of the company's product portfolio.

http://www.companiesandmarkets.com/link.asp?id=8EHYYD69659917

CONTACT: Mike King, Director, www.companiesandmarkets.com
Tel: +44 7813 784 393
Fax: +44 1536 790 144
e-mail: info@companiesandmarkets.com
WWW: http://www.companiesandmarkets.com/link.asp?id=8EHYYD69659917

M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.

For full details on (OMRI) OMRI. (OMRI) has Short Term PowerRatings at TradingMarkets. Details on (OMRI) Short Term PowerRatings is available at This Link.